<Record>
<Term>CTP-37</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Vaccine Antigen</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Agent/Antigen/Vaccine Antigen/CTP-37</ClassificationPath>
<BroaderTerm>CTP-37</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Biological Agent</BroaderTerm>
<BroaderTerm>Antigen</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Vaccine Antigen</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>CTP-37</Synonym>
<Description>A synthetic peptide vaccine consisting of the carboxy terminal peptide (CTP) of human beta chorionic gonadotropin (beta-hCG).  Vaccination with CTP-37 may stimulate the host immune system to produce antibodies against beta-HCG, leading to a decrease in the proliferation of tumor cells that overexpress beta-HCG. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
